Valentina V. Ignatova

Valentina V. Ignatova

Auto-generated profile, based on publicly available information

Valentina V. Ignatova

Institute of Functional Epigenetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
VIValentina V. Ignatova
Valentina V. Ignatova
SKSteffen Kaiser
Steffen Kaiser
JHJessica Sook Yuin Ho
Jessica Sook Yuin Ho
XBXinyang Bing
Xinyang Bing
PSPaul Stolz
Paul Stolz
RSRobert Schneider
Robert Schneider
Recently, covalent modifications of RNA, such as methylation, have emerged as key regulators of all aspects of RNA biology and have been implicated in numerous diseases, for instance, cancer. Here, we undertook a combination of in vitro and in vivo screens to test 78 potential methyltransferases for their roles in hepatocellular carcinoma (HCC) cell proliferation. We identified methyltransferase-like protein 6 (METTL6) as a crucial regulator of tumor cell growth. We show that METTL6 is a bona fide transfer RNA (tRNA) methyltransferase, catalyzing the formation of 3-methylcytidine at C32 of specific serine tRNA isoacceptors. Deletion of Mettl6 in mouse stem cells results in changes in ribosome occupancy and RNA levels, as well as impaired pluripotency. In mice, Mettl6 knockout results in reduced energy expenditure. We reveal a previously unknown pathway in the maintenance of translation efficiency with a role in maintaining stem cell self-renewal, as well as impacting tumor cell growth profoundly.